Related Experiment Video
Updated: Jul 19, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Hyperglycemia is a risk factor for early death and morbidity in extremely low birth-weight infants
Stephane P Hays1, E O'Brian Smith, Agneta L Sunehag
1USDA/ARS Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, 1100 Bates St, Houston, TX 77030, USA.
Insights
Hyperglycemia is common in extremely low birth-weight infants and increases risks for death, severe brain bleeds, and longer hospital stays. Managing blood glucose may improve outcomes for these vulnerable infants.
Area of Science:
- Neonatalogy
- Pediatric Endocrinology
- Clinical Research
Background:
- Extremely low birth-weight (ELBW) infants often experience metabolic disturbances.
- Hyperglycemia is a frequent complication in parenterally fed ELBW infants.
- The impact of hyperglycemia on adverse outcomes in ELBW infants requires further elucidation.
Purpose of the Study:
- To determine the prevalence of hyperglycemia in ELBW infants.
- To investigate if hyperglycemia elevates the risk of early adverse outcomes (death or severe intraventricular hemorrhage).
- To assess the effect of hyperglycemia on hospital stay duration in survivors without severe intraventricular hemorrhage.
Main Methods:
- Retrospective chart review of 93 ELBW infants admitted in 2001.
- Averaged key physiological parameters (blood glucose, dopamine, oxygen, sodium) during the first week of life or until adverse events.
- Calculated time ratio for blood glucose >150 mg/dL in survivors without severe intraventricular hemorrhage.
Main Results:
- Over 50% of ELBW infants exhibited persistent hyperglycemia (>150 mg/dL) in the first week.
- Higher average blood glucose concentrations correlated with adverse outcomes, interacting with Clinical Risk Index for Babies score and inspired oxygen levels.
- Increased hospital stay duration was linked to hyperglycemia duration, interacting with birth weight and inspired oxygen levels.
Conclusions:
- Confirms high prevalence of hyperglycemia in parenterally fed ELBW infants.
- Elevated blood glucose levels are associated with increased risk of early mortality, severe intraventricular hemorrhage, and prolonged hospitalization.
- Suggests that hyperglycemia prevention and management could significantly improve outcomes for ELBW infants.
Objectives:
The objectives of this study were to determine the prevalence of hyperglycemia in extremely low birth-weight infants and to determine whether hyperglycemia increases the risk of early adverse outcomes (death or intraventricular hemorrhage of grade 3 or 4) and/or affects the length of hospital stay among survivors without intraventricular hemorrhage.
Methods:
The charts of all extremely low birth-weight infants (n = 93) admitted to Texas Children's Hospital (Houston, TX) during 2001 were reviewed. The highest daily blood glucose concentrations, highest dopamine infusion rates, highest daily percentage of inspired oxygen, and mean blood sodium concentrations were averaged over the first week of life or before death or occurrence of grade 3 or 4 intraventricular hemorrhage. Among survivors without severe intraventricular hemorrhage, the time ratio for blood glucose concentrations of >150 mg/dL was calculated.
Results:
More than 50% of the infants had persistent blood glucose concentrations of >150 mg/dL during their first week of life. Early adverse outcomes were associated with the average highest daily blood glucose concentration through interaction with the Clinical Risk Index for Babies score and with the average highest daily percentage of inspired oxygen. The length of hospital stay was associated with the time ratio for blood glucose concentrations of >150 mg/dL through interaction with birth weight and the average highest daily percentage of inspired oxygen.
Conclusion:
These data confirm the high prevalence of hyperglycemia among parenterally fed, extremely low birth-weight infants and show that high blood glucose concentrations increase the risk of early death and grade 3 or 4 intraventricular hemorrhage and the length of hospital stay among survivors without intraventricular hemorrhage, which suggests that prevention and treatment of hyperglycemia may improve the outcomes of extremely low birth-weight infants.
Related Concept Videos
Hypoglycemia
Hyperglycemia
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational
Hypoglycemia and Glucagon
Diabetes: Symptoms, Diagnosis, and Complications
